Uncategorised Sickle Cell Society’s response to Crizanlizumab (Adakveo), on an interim basis for use by NHS Scotland. 11 Jul 2022 Sickle Cell Society’s response to the Scottish Medicines Consortium SMC Committee’s decision to accept Crizanlizumab... Read More
